2024
EHA l European Hematology Association’s Annual Congress
Høydepunkter EHA 2023
Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment
/ Evangelos Terpos / Jan Andreasen
Abstracts fra EHA 2023
Onkologi / Hematologi • Nr. 9 • 2023
- Highlights from ASCO GI & GU
- LAG3 Inhibitors Changing the Treatment Landscape of Immunotherapy
- Highlights from ASH 2022
- New Treatments for Acute Myeloid Leukemia
Mer fra EHA
Danish study shows increased mortality in patients with CLL and type 2 diabetes
/ Emelie Hamotal Curovic Rotbain
CRTH Award Winning Study Demonstrates Malignancy Risks for CLL Patients
/ Thomas Chatzikonstantinou
Carfilzomib-lenalidomide-dexamethasone konsolidering i myelomatosepasienter
/ Jakob Nordberg Nørgaard